Brenda Lee

Brenda Lee is a Research Associate at Quintara Biosciences in the NGS Division since December 2022. Prior experience includes serving as a Research Specialist in the Synthetic Lethality - Oncology Unit at GSK from September 2021 to November 2022 and working as a Technical Lab Specialist at PerkinElmer. Brenda's early research roles include being an Undergraduate Research Assistant at Rutgers University–New Brunswick in the Laboratory of David Barker, PhD, at the Brain Health Institute from 2019 to 2021, and at the Massachusetts Institute of Technology in the Laboratory of Guoping Feng, PhD, in 2020, as well as at Northeastern University in the Laboratory of Lisa Feldman Barrett, PhD, in 2019. Currently pursuing a Master of Science in Communication Sciences and Disorders with a focus on Speech Pathology at New York University, Brenda holds a Bachelor's degree in Linguistics and Psychology from Rutgers University–New Brunswick, completed in May 2021, and graduated from Montgomery High School in June 2017.